Background and aim Non-alcoholic fatty liver disease (NAFLD), affecting up to around 30%
of the world's adult population, causes considerable liver-related and extrahepatic morbidity …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in many developed countries, affecting an estimated 30% of the adult population. In this …

Abstract Background/Aim Non‐alcoholic fatty liver disease (NAFLD) affects approximately
25% of the global adult population. The aim of this narrative review is to describe the …

Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in
Western countries and affects approximately 25% of the adult population. Since NAFLD is …

Non-alcoholic fatty liver disease (NAFLD) is a public health problem, affecting up to a third of
the world's adult population. Several cohort studies have consistently documented that …

Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide
and may confer increased cardiometabolic risk with consequent adverse cardiovascular …

Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver
diseases worldwide, causing considerable liver-related mortality and morbidity. During the …

Nonalcoholic fatty liver disease (NAFLD) is a pathologic condition frequently observed in
clinical practice. To date, the prevalence of NAFLD is approximately 25–30% among adults …

Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of
metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by …

Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …